Terns Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2024 | 7 | -$0.36 | -$0.29 | -$0.32 |
| Q3 2024 | 2 | -$0.32 | -$0.32 | -$0.32 |
| Q1 2025 | 3 | -$0.35 | -$0.35 | -$0.35 |
| Q2 2025 | 3 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2025 | 6 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2025 | 5 | -$0.34 | -$0.34 | -$0.34 |
Terns Pharmaceuticals, Inc. Earnings Date And Information
Terns Pharmaceuticals, Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-0.31 earnings per share for the quarter, topping analysts' consensus estimates of $-0.35 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Terns Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-1.27 diluted earnings per share) and currently has a price-to-earnings ratio of -5.51. Terns Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Terns Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2024 | Q2 2024 | -$0.35 | -$0.31 | 0.04 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.36 | -$0.30 | 0.06 | $0 | |
| 03/14/2024 | Q4 2023 | -$0.29 | -$0.29 | 0 | $1.32 M | |
| 09/29/2023 | Q3 2023 | -$0.42 | $0 | |||
| 08/08/2023 | Q2 2023 | -$0.32 | -$0.25 | 0.07 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.28 | -$0.31 | -0.03 | $0 | |
| 03/27/2023 | Q4 2022 | -$0.42 | -$0.29 | 0.13 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.51 | -$0.44 | 0.07 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.63 | -$0.55 | 0.08 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.67 | -$0.55 | 0.12 | $0 | |
| 03/07/2022 | Q4 2021 | -$0.56 | $1.00 M | |||
| 11/15/2021 | Q3 2021 | -$0.60 | -$0.47 | 0.13 | $0 | |
| 08/16/2021 | Q2 2021 | -$0.81 | -$0.43 | 0.38 | $0 | |
| 05/14/2021 | Q1 2021 | -$0.88 | $0 | |||
| 03/30/2021 | Q4 2020 | -$0.91 | -$0.65 | 0.26 | $0 | |
| 09/29/2020 | Q3 2020 | -$0.48 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.40 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.38 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.41 | $0 |
Terns Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Terns Pharmaceuticals, Inc.'s earnings date?
Terns Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Terns Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Terns Pharmaceuticals, Inc. (:TERN) reported $-0.31 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.35 by $0.04.
-
How can I listen to Terns Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Terns Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Terns Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Terns Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Terns Pharmaceuticals, Inc. generate each year?
Terns Pharmaceuticals, Inc. (:TERN) has a recorded net income of $0. Terns Pharmaceuticals, Inc. has generated $-1.27 earnings per share over the last four quarters.
-
What is Terns Pharmaceuticals, Inc.'s price-to-earnings ratio?
Terns Pharmaceuticals, Inc. (:TERN) has a price-to-earnings ratio of -5.51 and price/earnings-to-growth ratio is 1.16.
